H. H. Doss

Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

John D. Hainsworth, Ian W. Flinn, David R. Spigel et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 32 citations

Medicine, Oncology, Pharmacotherapy +10

Induction chemotherapy + gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients (pts) with locally advanced squamous carcinoma of the head and neck: A phase I/II trial of the Minnie Pearl Cancer Research Network

H. H. Doss, F. Anthony Greco, Anthony A. Meluch et al. · Journal of Clinical Oncology · 2006 · 23 citations

Medicine, Oncology, Pharmacotherapy +17

A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors

H. H. Doss, Suzanne F. Jones, J. R. Infante et al. · Journal of Clinical Oncology · 2008 · 21 citations

Medicine, Oncology, Pharmacology +11

Phase II Trial of Ofatumumab (OFA) for Older Patients and Patients Who Refuse Fludarabine-Based Regimens with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Ian W. Flinn, William N. Harwin, Patrick J. Ward et al. · Blood · 2012 · 12 citations

Pharmacy, Oncology, Pharmacotherapy +17

5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Ian W. Flinn, Ines Macias‐Perez, Patrick S. Tucker et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +17